FDA issued a Warning Letter to Boehringer Ingelheim Pharma GMBH & Co on 5/6/2013 for a later inspection.
483 Boehringer Ingelheim Pharma Gmbh & Co Kg Jun 2002

483 Boehringer Ingelheim Pharma Gmbh & Co Kg Jun 2002

Mariza Jafary FDA, Robert Jennings FDA$595.00 - Available Now

FDA investigators audited the Boehringer Ingelheim Pharma Gmbh & Co Kg - Biberach an der Ris, Germany facility and issued inspectional observations (via FDA 483) on 20 Jun 2002.

Product details

  • Category: Biologics
  • Inspection end: 20 Jun 2002
  • Location: Biberach an der Ris, Germany
  • FEI: 3002806518
Add To Cart